4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029905
Chief R&D Officer sold 21,673 shares at $3.95 ($85,608)
- Chief R&D Officer acquired 23,950 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…